Adrenergic uptake inhibitor: Difference between revisions
imported>Robert Badgett |
mNo edit summary |
||
| Line 12: | Line 12: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:00, 6 July 2024
In medicine and pharmacology, adrenergic uptake inhibitors are medications that "block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin."[1]
Medical uses
Depression
Depression may be due to the monoamine-deficiency hypothesis, which is a "deficiency in serotonin or norepinephrine neurotransmission in the brain."[2]
By blocking the reuptake of norepinephrine and serotonin, adrenergic update inhibitors may overcome the mono-amine deficiency.[3]
Attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder may be treated by the selective norepinephrine reuptake inhibitor, atomoxetine.
References
- ↑ Anonymous (2024), Adrenergic uptake inhibitor (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Belmaker RH, Agam G (2008). "Major depressive disorder". N. Engl. J. Med. 358 (1): 55–68. DOI:10.1056/NEJMra073096. PMID 18172175. Research Blogging.
- ↑ Katzung, Bertram G. (2006). “Antidepressant Agents”, Basic and Clinical Pharmacology, 10th. New York: McGraw-Hill Medical Publishing Division. ISBN 0-07-145153-6.